Jonathan Glass & Nick Boulis – Q&A at TEDMED 2012
Neurologist Jonathan Glass and neurosurgeon Nick Boulis ask: Should acceptable risk levels for experimental treatments be recalibrated for the terminally ill with no other options?
Latest Posts
E.O. Wilson – Q&A at TEDMED 2012
E.O. Wilson answers talks about his advice to young scientists and students, including why imagination is central to scientific discovery.
Was Einstein right about imagination?
Renowned biologist E.O. Wilson offers advice to young scientists, exhorting them to “think like a poet and work like a bookkeeper” and to “step away from the blackboard,” …
Atul Butte – Q&A at TEDMED 2012
Atul Butte, Chief of Systems Medicine at Stanford University, answers questions about outsourcing research online.
How many engineers does it take to fight cancer?
The Novocure executive director presents tumor treating fields (TTF) therapy, which uses electric fields to kill procreating cancer cells, shrinking tumors or slowing growth with few if any …
Barton Kamen at TEDMED 2011 – Q and A
The pediatrician talks about how his own rare tumor changed his approach to medicine, and offers advice on how to be a good patient.
Aneesh Chopra and Farzad Mostashari at TEDMED 2011 – Q and A
The duo fields audience questions about the potential unintended consequences of collecting electronic health record data.
What happens if the government shares health data openly?
Mostashari, National Coordinator for Health IT at the DHHS, and Chopra, the U.S. CTO, talk about how open access to electronic health data can reform physician pay and …
Sheila Nirenberg at TEDMED 2011 – Q and A
The neuroscientist talks about developing a revolutionary non-surgical artificial retina that translates the eye’s neural “code.”
Can we speak the language of the brain?
Decoding sight: Neuroscientist Nirenberg is developing a non-surgical and vastly improved artificial retina strategy that deciphers neural cell codes, potentially reversing some types of blindness.